Dr. Vikas Malhotra, MD

Dr. Malhotra practices at HCA Florida Oak Hill Hospital in Brooksville, Florida, part of HCA Healthcare.

Dr. Malhotra's NPI, 1821058496, was assigned on March 27, 2006. Dr. Malhotra graduated from Maulana Azad Medical College in 1992. Dr. Malhotra holds Florida license ME87732.

Dr. Malhotra's primary practice is HCA Florida Oak Hill Hospital, at 11375 Cortez Blvd, Brooksville, FL 34613 in Hernando County. The practice phone is (352) 596-6632.

Dr. Malhotra's primary practice is HCA Florida Oak Hill Hospital in Brooksville, Florida, part of HCA Healthcare. Dr. Malhotra is also affiliated with Tampa General Hospital Brooksville. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Malhotra to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Malhotra practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Malhotra's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Malhotra is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Malhotra's licenses on file in 3 states: Florida, Missouri and Iowa.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and immune deficiency disease among the conditions Dr. Malhotra treats.

CMS data shows 372,028 Medicare services from Dr. Malhotra across 56 procedure codes in 2024, for 1,280 Medicare patients. Medicare paid $3,686,493 for them. Every service was in an office.

CMS counts 1,280 Medicare patients who saw Dr. Malhotra in 2024. The largest group is 75 to 84, with 552 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Malhotra's median patient age at 68, with 65% women.

In 2024, Dr. Malhotra wrote 4,338 Medicare Part D claims for 647 patients. 82% of them were for generic drugs. CMS names the drug for 3,950 of them, across 71 drugs with 11 or more claims each, at $5,870,327 in total drug cost. In 2023, CMS named 3,449 claims across 68 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Malhotra for performance year 2024, reported as part of a group. Dr. Malhotra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Malhotra as offering telehealth.

Dmand AI links 23 papers to Dr. Malhotra, published from 2014 to 2023. 2022 was the busiest year, with 4. The most frequent topics are COVID-19, SARS-CoV-2 and Antineoplastic Combined Chemotherapy Protocols. Dr. Malhotra has published most often in Cureus. Dr. Malhotra's most frequent co-authors are Amit Kumar Agarwal, MD, Nikhil Arora, MD and Mohit Gupta, MD.

CMS Open Payments shows 1,428 general payments to Dr. Malhotra from 98 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. AstraZeneca Pharmaceuticals LP paid the most, $15,271.

Dmand AI lists 1 award for Dr. Malhotra, most recently CMS Stage 1 EHR in 2014.

Dr. Malhotra graduated from Maulana Azad Medical College in 1992.

Dr. Malhotra is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.